CA2296869A1 - Une lipoproteine a surface exposee de campylobacter jejuni participant a l'adhesion aux cellules hep-2 - Google Patents

Une lipoproteine a surface exposee de campylobacter jejuni participant a l'adhesion aux cellules hep-2 Download PDF

Info

Publication number
CA2296869A1
CA2296869A1 CA 2296869 CA2296869A CA2296869A1 CA 2296869 A1 CA2296869 A1 CA 2296869A1 CA 2296869 CA2296869 CA 2296869 CA 2296869 A CA2296869 A CA 2296869A CA 2296869 A1 CA2296869 A1 CA 2296869A1
Authority
CA
Canada
Prior art keywords
nucleic acid
protein
jejuni
sample
jipa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2296869
Other languages
English (en)
Inventor
Angela Joe
Songmu Jin
Voon Loong Chan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2296869 priority Critical patent/CA2296869A1/fr
Publication of CA2296869A1 publication Critical patent/CA2296869A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
CA 2296869 2000-01-24 2000-01-24 Une lipoproteine a surface exposee de campylobacter jejuni participant a l'adhesion aux cellules hep-2 Abandoned CA2296869A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2296869 CA2296869A1 (fr) 2000-01-24 2000-01-24 Une lipoproteine a surface exposee de campylobacter jejuni participant a l'adhesion aux cellules hep-2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2296869 CA2296869A1 (fr) 2000-01-24 2000-01-24 Une lipoproteine a surface exposee de campylobacter jejuni participant a l'adhesion aux cellules hep-2

Publications (1)

Publication Number Publication Date
CA2296869A1 true CA2296869A1 (fr) 2001-07-24

Family

ID=4165147

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2296869 Abandoned CA2296869A1 (fr) 2000-01-24 2000-01-24 Une lipoproteine a surface exposee de campylobacter jejuni participant a l'adhesion aux cellules hep-2

Country Status (1)

Country Link
CA (1) CA2296869A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049641A2 (fr) * 2003-11-21 2005-06-02 Ace Biosciences A/S Polypeptides de campylobacter jejuni localises en surface

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049641A2 (fr) * 2003-11-21 2005-06-02 Ace Biosciences A/S Polypeptides de campylobacter jejuni localises en surface
WO2005049641A3 (fr) * 2003-11-21 2005-10-20 Ace Biosciences As Polypeptides de campylobacter jejuni localises en surface
JP2008501625A (ja) * 2003-11-21 2008-01-24 エース バイオサイエンシズ エー／エス 表在Ｃａｍｐｙｌｏｂａｃｔｅｒｊｅｊｕｎｉポリペプチド

Similar Documents

Publication Publication Date Title
KR101078919B1 (ko) 신규한 스트렙토코커스 항원
JP4651703B2 (ja) 新規表面抗原
JP4271952B2 (ja) ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質
WO2003054007A2 (fr) Antigenes de streptococcus
JP2008029344A (ja) 新規化合物
JP2009173667A (ja) 病原菌のｔｉｒ遺伝子によってコードされる、病原菌の宿主の膜受容体、ｈｐ９０
US6143872A (en) Borrelia burdorferi Osp A and B proteins and immunogenic peptides
JP2002525083A (ja) Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ遺伝子およびポリペプチド
KR0170752B1 (ko) 혈호균속 인플루엔자용 백신과 진단검사법
US6444804B1 (en) Proteins involved in the synthesis and assembly of core lipopolysaccharide of Pseudomonas aeruginosa
US20040096973A1 (en) Environmentally regulated genes of Streptococcus suis
AU762100B2 (en) Protective antigen of group A Streptococci (SPA)
JPH10210988A (ja) 新規トポイソメラーゼｉ
US6107464A (en) iceA gene and related methods
CA2296869A1 (fr) Une lipoproteine a surface exposee de campylobacter jejuni participant a l'adhesion aux cellules hep-2
CA2227932A1 (fr) Gene codant pour la proteine associee a l'invasion par campylobacter jejuni
JPH10113189A (ja) 新規 ＲＮａｓｅＰ
US7208574B1 (en) Host receptor for pathogenic bacteria
JPH10201484A (ja) 新規ＦｔｓＬ
WO1997003359A1 (fr) POLYPEPTIDES ClpB D'HELICOBACTER
NZ538864A (en) Use of neisseria meningitidis gene comprising the nucleotide sequence SEQ ID NO:29 for treating or preventing a condition associated with infection by neisseria or gram-negative bacteria
US9150622B2 (en) Immune system modulating composition
JP2002534960A (ja) ワクチン
WO2005116062A1 (fr) Produits et ses utilisations
JPH10327882A (ja) 新規ＬｉｃＢ

Legal Events

Date Code Title Description
FZDE Dead